| Literature DB >> 33816473 |
Suresh Kumar1, Trilochan Mohapatra2.
Abstract
Gene regulation depends on dynamic and reversibly modifiable biological and chemical information in the epigenome/epitranscriptome. Accumulating evidence suggests that messenger RNAs (mRNAs) are generated in flashing bursts in the cells in a precisely regulated manner. However, the different aspects of the underlying mechanisms are not fully understood. Cellular RNAs are post-transcriptionally modified at the base level, which alters the metabolism of mRNA. The current understanding of epitranscriptome in the animal system is far ahead of that in plants. The accumulating evidence indicates that the epitranscriptomic changes play vital roles in developmental processes and stress responses. Besides being non-genetically encoded, they can be of reversible nature and involved in fine-tuning the expression of gene. However, different aspects of base modifications in mRNAs are far from adequate to assign the molecular basis/functions to the epitranscriptomic changes. Advances in the chemogenetic RNA-labeling and high-throughput next-generation sequencing techniques are enabling functional analysis of the epitranscriptomic modifications to reveal their roles in mRNA biology. Mapping of the common mRNA modifications, including N 6-methyladenosine (m6A), and 5-methylcytidine (m5C), have enabled the identification of other types of modifications, such as N 1-methyladenosine. Methylation of bases in a transcript dynamically regulates the processing, cellular export, translation, and stability of the mRNA; thereby influence the important biological and physiological processes. Here, we summarize the findings in the field of mRNA base modifications with special emphasis on m6A, m5C, and their roles in growth, development, and stress tolerance, which provide a new perspective for the regulation of gene expression through post-transcriptional modification. This review also addresses some of the scientific and technical issues in epitranscriptomic study, put forward the viewpoints to resolve the issues, and discusses the future perspectives of the research in this area.Entities:
Keywords: 5-methylcytidine; N6-methyladenosine; RNA metabolism; RNA modification; central dogma; epitranscriptomics; mRNA methylation; post-transcriptional regulation
Year: 2021 PMID: 33816473 PMCID: PMC8010680 DOI: 10.3389/fcell.2021.628415
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
FIGURE 1Reversible biochemical modifications affect the transfer of genetic information (the Central Dogma). As per the central dogma, the genetic information passes from DNA, through RNA, to protein. However, epigenetic DNA base modifications [e.g., 5-methylcytosine (5-mC), 5-hydroxymethylcytosine (5-hmC), N6-methyladenine (6-mA), and N6-hydroxymethyladenine (6-hmA)] and histone protein modifications [e.g., methylation (me) and acetylation (ac) of amino acids] affects RNA metabolism (including splicing, export, stability, and translation efficiency) and play crucial roles in the regulation of cellular growth, development, and protection from environmental stress. Similarly, the dynamic RNA modifications [e.g., N6-methyladenosine (m6A), N1-methyladenosine (m1A), and N6-hydroxymethyladenosine (hm6A)] encrypt an additional layer of information and dynamically regulate the biological processes. Small-interfering RNA (siRNA) plays important role in recruitment of DNA methyltranferase for DNA base modification, methylated mRNA bases (e.g., m6A) play role in protein synthesis, the histone 3 (H3) protein trimethylated (me3) at 4th lysine of (H3K4me3) affects the transcription process.
FIGURE 2Base modifications in mRNA affect post-transcriptional gene regulation. In the nucleus, RNA base modifications affect (1) pre-mRNA processing and (2) pri-miRNA maturation, and (3) their export from the nucleus. In the cytoplasm, RNA base modifications regulate (4) mRNA degradation, (5) mRNA stability, (6) RNA structure, and (7) mRNA translation efficiency.
Modified RNA bases, their modulators, and interpreters.
| RNA base modification | Enzymes/proteins | References | |||||
| Writer | Eraser | Reader | |||||
| Animal | Plant | Animal | Plant | Animal | Plant | ||
| Pseudouridine (Ψ) | PUS1, PUS2, PUS3, PUS4, PUS6, PUS7, PUS9, PUS13 DKC1, BoxH/ACA | ? | ? | ? | ? | ? | |
| METTL3, METTL14 METTL16 WTAP RBM15B VIRMA ZC3H13 HAKAI Spenito | MTA, MTB FIP37 VIR HAKAI | ALKBH5 FTO | ALKBH9B ALKBH10B SIALKDH2 | YTHDC1 YTHDC2 YTHDF1 YTHDF2 YTHDF3 eIF3 HNRNPC HNRNPA2B1 SRSF2 | ECT2 ECT3 ECT4 COSF30L | ||
| TRMT61B, TRMT10C, and the complex of TRMT6, TRMT61A | ? | ALKBH1 ALKBH3 | ? | ? | ? | ||
| CMTR1 CMTR2 PCIF | ? | FTO | ? | ? | ? | ||
| 5-methylcytidine (m5C) | NSUN2 DNMT2 | TRM4B | ? | ? | ALYREF YBX1 | ? | |
| 5-hydroxymethylcytidine (hm5C) | TET1, TET2, TET3 | ? | ? | ? | ? | ? | |
Techniques for detection of modified RNA base.
| Method/technique | Base modification | Detection principle | References |
| Thin layer chromatography (TLC*), SCARLET | m6A, m5C | Difference in the net charge, polarity, and hydrophobicity. Radioactive (32P) labeling increases sensitivity of the SCARLET technique. | |
| HPLC, LC-MS/MS*, Dot-blot*. | m6A, m1A, m5C, hm5C | The RNA is digested into mononucleotides and detected on HPLC using UV light or mass spectrometry. In case of LC-MS/MS, modified base is quantified using the nucleoside-to-base ion mass transition. In dot-blot (a semiquantitative method), modified base-specific (e.g., anti-m5C) antibody is used to detect the modified base. | |
| Single-molecule real-time (SMRT) technology. | m6A, m1A | The modified adenine (6-mA) can be discriminated from the unmodified adenine (A). | |
| Chemical pretreatment approach, ICE-Seq | Inosine (I) | Acrylonitrile treatment causes inosine-specific cyanoethylation leading to the truncation of reverse transcription, allowing inosine (I) sites to be detected by subsequent RNA-sequencing. | |
| Modification-specific RT signature technique | Inosine | The modified nucleotide leaves specific signatures in the cDNA sequences, which cause either abortive primer extension and/or misincorporation at or around the modified site. | |
| m1A | Modified nucleotide affects cDNA synthesis either due to its inability to base-pair with its regular partner or by slowing down the rate of cDNA synthesis due to its massive or highly hydrophobic structure. | ||
| Biological/chemical induction of modification-specific RT signature | Pseudouridine (ψ), | Pseudouridine reacts with carbodiimide (CMCT) and forms a stable adduct, while U-CMC adducts are removed by alkaline treatment. The resulting ψ-CMC generates RT-arrest, which is detectable in the sequencing profile. | |
| m5C | 5-mC is RT silent, but it is insensitive to bisulfite deamination. Cytosine (C) residue is deaminated into Uracil due to bisulfite treatment. The presence of C is detected by sequencing, wherein it is replaced by uracil. | ||
| Ribose 2′- | |||
| Antibody-based method, MeRIP-isolated by crosslinking immunoprecipitation-seq (MeRIP-iCIP), MeRIP-qPCR*, MeRIP-seq* | m6A, m5C, hm5C, m1A | Modification-specific (anti-6-mA) antibody used to immunoprecipitate short RNA fragments, followed by cDNA libraries preparation and sequencing. | |
| Modified bisulfite (BS-seq*) strategy | m5C | Bisulfite treatment converts unmodified cytosine (C) to uracil, but 5-mC remains unchanged. The presence of C is detected by sequencing, wherein it is replaced by uracil. | |
| Ψ | CMC specifically labels Ψ forming CMC-Ψ adducts which stop RT at one nucleotide 3′ to the labeled Ψ site, thereby allows base-resolution detection of Ψ. | ||
| Antibody-free method, MAZTER-seq, m6A-REF-seq, DART-seq, m6A-label-seq, m6A-SEAL* | m6A | Endoribonuclease-based RNA digestion with m6A-sensitive RNase ( |
FIGURE 3Detection of modified bases in mRNA. (A) Bisulfite sequencing (BS-seq) for the detection of 5-methylcytosine (m5C). Purified mRNA is fragmented into small (100–200 nt) fragments, and subjected to bisulfite treatment. Bisulfite treatment causes converts cytosine (C) to uracil (U), but m5C remains unchanged. Presence of C is detected by sequencing, wherein it is replaced by T. (B) Purified mRNAs are fragmented into 100–200 nt, followed by immunoprecipitation using anti-m6A antibody to enrich the sample with fragments containing the modified base, library preparation, and high-throughput deep-sequencing for detection of m6A. (C) Purified mRNAs are fragmented followed by immunoprecipitation using anti-m5C antibody of the fragments containing the modified base, library preparation, and sequencing. (D) m5C individual-nucleotide-resolution crosslinking and immunoprecipitation (m5C-miCLIP) exploites catalytic activity of cysteine-to-alanine mutation (C271A) mutant of NSUN2 (methyltransferase) which inhibits release of the enzyme from the protein–RNA complex making stable covalent bond between NSun2 and its RNA targets. Antibody specific to the RNA bound protein is used for immunoprecipitation, followed by library preparation and sequencing. This allows detection of low-abundance methylated RNAs without the need of deep sequencing.